"US Court Upholds Martin Shkreli's Lifetime Ban from Pharmaceutical Industry"

TL;DR Summary
Martin Shkreli, infamously known as "pharma bro," has had his lifetime ban from the pharmaceutical industry upheld by a US court. The ban was imposed due to his antitrust violations, including the astronomical price increase of a life-saving drug. Shkreli's appeal was rejected, and he was ordered to repay $64.6m. The court emphasized the likelihood of his past misconduct recurring and the life-threatening nature of its results. Shkreli's lawyer indicated the possibility of a further appeal, while the FTC hailed the decision as a win for consumers seeking affordable medication.
Topics:nation#antitrust-violations#court-ruling#legalpharmaceutical-industry#lifetime-ban#martin-shkreli#pharmaceutical-industry
- Martin Shkreli ban from pharmaceutical industry upheld by US court The Guardian US
- Martin Shkreli's lifetime drug industry ban upheld | REUTERS Reuters
- New York AG pushing for lifetime Trump ban cites Martin Shkreli ruling CNBC
- 'Pharma Bro' Martin Shkreli's lifetime drug industry ban upheld New York Post
- Martin Shkreli's lifetime industry ban upheld WQAD News 8
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
78%
416 → 90 words
Want the full story? Read the original article
Read on The Guardian US